Mario Mikula
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
mTORC2 inhibition reduces tumor burden via STAT1 activation and enhanced response to anti-PD-L1 therapy.
Journal: Cell death & disease
Published: June 06, 2025
Expression of the cholesterol transporter SR-B1 in melanoma cells facilitates inflammatory signaling leading to reduced cholesterol synthesis.
Journal: Neoplasia (New York, N.Y.)
Published: February 04, 2025
Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.
Journal: British journal of cancer
Published: August 21, 2023
Dynamic regulation of tumour progression by phenotype-switching drivers.
Journal: Clinical and translational medicine
Published: April 05, 2022
Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.
Journal: Cancer medicine
Published: November 02, 2021
Plasma Membrane Lipids: An Important Binding Site for All Lipoprotein Classes.
Journal: Membranes
Published: October 12, 2021
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
Journal: Oncogene
Published: February 19, 2020
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Journal: Cell death & disease
Published: August 14, 2019
Metabolism of cholesterol and progesterone is differentially regulated in primary trophoblastic subtypes and might be disturbed in recurrent miscarriages.
Journal: Journal of lipid research
Published: February 22, 2019
Loss of SR-BI Down-Regulates MITF and Suppresses Extracellular Vesicle Release in Human Melanoma.
Journal: International journal of molecular sciences
Published: February 13, 2019
Last Updated: 09/26/2026